LEVOSIMENDAN: 183 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
183
Total FAERS Reports
37 (20.2%)
Deaths Reported
103
Hospitalizations
183
As Primary/Secondary Suspect
55
Life-Threatening
First Report: 1998 · Latest Report: 20240131
What Are the Most Common LEVOSIMENDAN Side Effects?
#1 Most Reported
Drug ineffective
64 reports (35.0%)
#2 Most Reported
Hypotension
37 reports (20.2%)
#3 Most Reported
Cardiac failure
37 reports (20.2%)
All LEVOSIMENDAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 64 | 35.0% | 10 | 41 |
| Cardiac failure | 37 | 20.2% | 10 | 30 |
| Hypotension | 37 | 20.2% | 6 | 28 |
| Off label use | 28 | 15.3% | 0 | 19 |
| Respiratory failure | 27 | 14.8% | 4 | 16 |
| Constipation | 16 | 8.7% | 0 | 16 |
| Hypothyroidism | 16 | 8.7% | 0 | 16 |
| Ejection fraction decreased | 15 | 8.2% | 4 | 14 |
| Jugular vein distension | 14 | 7.7% | 0 | 14 |
| Pulmonary hypertension | 13 | 7.1% | 0 | 11 |
| Condition aggravated | 12 | 6.6% | 8 | 11 |
| Cardiogenic shock | 11 | 6.0% | 1 | 10 |
| Therapy non-responder | 11 | 6.0% | 4 | 6 |
| Acidosis | 10 | 5.5% | 0 | 0 |
| Pallor | 10 | 5.5% | 0 | 1 |
| Peripheral swelling | 10 | 5.5% | 0 | 10 |
| Blood pressure abnormal | 9 | 4.9% | 0 | 9 |
| Bronchopulmonary dysplasia | 9 | 4.9% | 0 | 0 |
| Cyanosis | 9 | 4.9% | 0 | 9 |
| Device related sepsis | 9 | 4.9% | 0 | 0 |
Who Reports LEVOSIMENDAN Side Effects? Age & Gender Data
Gender: 42.5% female, 57.5% male. Average age: 49.9 years. Most reports from: ES. View detailed demographics →
Is LEVOSIMENDAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2010 | 5 | 0 | 0 |
| 2012 | 1 | 1 | 0 |
| 2015 | 4 | 1 | 0 |
| 2016 | 2 | 0 | 1 |
| 2017 | 17 | 5 | 13 |
| 2018 | 4 | 0 | 3 |
| 2019 | 4 | 1 | 2 |
| 2020 | 7 | 1 | 3 |
| 2021 | 4 | 0 | 0 |
| 2022 | 8 | 1 | 1 |
| 2024 | 2 | 0 | 0 |
What Is LEVOSIMENDAN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 47 |
| Cardiac failure | 29 |
| Cardiac failure congestive | 18 |
| Cardiogenic shock | 15 |
| Pulmonary hypertension | 10 |
| Cardiac failure acute | 9 |
| Haemodynamic instability | 5 |
| Hypotension | 5 |
LEVOSIMENDAN vs Alternatives: Which Is Safer?
LEVOSIMENDAN vs LEVOSULPIRIDE
LEVOSIMENDAN vs LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LIOTHYRONINE
LEVOSIMENDAN vs LEVOXYL
LEVOSIMENDAN vs LEXAPRO
LEVOSIMENDAN vs LEXISCAN
LEVOSIMENDAN vs LIALDA
LEVOSIMENDAN vs LIDOCAINE
LEVOSIMENDAN vs LIDOCAINE\MENTHOL
Official FDA Label for LEVOSIMENDAN
Official prescribing information from the FDA-approved drug label.